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ABSTRACT
Objective: Dyspepsia is a common disorder originating from the upper gastrointestinal tract, and is the 
most common indication for gastrointestinal endoscopy. Even though, functional dyspepsia (non-ulcer 
dyspepsia) is not life –threatening, it has profound clinical and economic effects, and influences the 
quality of life of sufferers. Data is scanty on functional dyspepsia from Nigeria. This study aims to 
determine the prevalence of functional dyspepsia in Yola, Nigeria.
Methods: This was a cross-sectional study carried out at the Gastroenterology unit of Federal Medical 
Centre, Yola from December, 2006 to October, 2010.
Patients with dyspepsia who had upper gastrointestinal endoscopy as part of their work-up were recruited. 
Their biodata, history and duration of dyspepsia were noted on a proforma. The spectrum of endoscopic 
findings was also noted.
Results: A total of 441 patients underwent upper gastrointestinal endoscopy out of which 299 patients had 
dyspepsia.  One hundred and thirteen (37.8%) were males while 186 (62.2%) were females, giving a male 
to female ratio of 1:1.6. The age range was from 18 to 97 years with a mean of 47.6 ± 9.4 years. Clinically 
significant endoscopic findings were seen in 94.0% while functional dyspepsia was seen in 18 patients 
(6.0%). 
Conclusions: Functional dyspepsia was seen in only a minority of patients with dyspepsia. 
Keywords: Functional dyspepsia, endoscopic,  Nigerians
*Corresponding author: Dr. Olokoba A. B. E-mail: drabolokoba@yahoo.com
1Department of medicine, University of Ilorin Teaching Hospital, Ilorin, Nigeria.
2 Department of Medicine, Federal Medical Centre, Yola, Nigeria.
3 Service de Medecine Interne et D'hepatogastroenterolgie, Centre Hospitalier Jacques Monod, France.
Res. J. of Health Sci. Vol 3(1). January/March 2015                                                 38
Functional dyspepsia in Nigeria                                                       Olokoba A B, et. al.
La dyspepsie fonctionnelle à Yola au Nigeria
1 2 3
* Olokoba  A B, Salawu F K, and  Vickola JA
Article Original
RÉSUMÉ
Contexte de L'Étude: La dyspepsie est un problè megastro-intestinalcommué provenant du tractus 
gastro-intestinal supérieur. Même si, la dyspepsie sans ulcèredyspepsie non-ulcéreuse ou la dyspepsia 
fonctionnelle) n'est pas une maladie mortelle, elle a des effets cliniques et économiques profondes et 
influe sur la qualité de vie des patients. Il y a un manqué de données sur la dyspepsia fonctionnelle du 
Nigeria. Le but de cette étude est de déterminer la prévalence de la dyspepsia fonctionnelle chez les 
patients dyspeptiques à Yola, Nigeria.
Méthodes: C'était une étude en milieu hospitalier et transversal réalisée à l'unité gastro-entérologie du 
centre medical fédéral, Yola de Décembre 2006, a Octobre, 2010.Les patients avec des caractéristiques 
cliniques de la dyspepsie qui ont subi un endoscope gastro-intestinalsuper aire dans le cadre de leur 
travail-up ont étérecrutés.Leur bio-informatique, histoire et la durée de la dyspepsie ont été notes sur une 
préformes Le spectre des resultants endoscopiques a également été noté.
Résultats: Un total de 441 patients ont été référés pour L'endoscopie gastro-intestinale supérieure dont 
299 patients avaient dyspepsie 113 (37.8%) étaient hommes alors que 186 (62.2%) étaient femmes, 
donnant un ratio homme-femme sur 1:16. Leur âge variât de 18 à 97 ans avec une moyenne de 47.6 9 4 ans.
Cliniquement constations endoscopiques significative a été observe chez – patients (94.0%) toute 
dyspepsia fonctionnelle a été observe chez 18 patients 6.0%.
Conclussion: La dyspepsia fonctionnelle a été observée que dans une minorité de patients souffrant de 
dyspepsie.
Mots Cles: Dyspepsie fonctionnelle, endoscopique, Nigérians.
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INTRODUCTION
Dyspepsia is a frequently recurring 
epigastric pain or discomfort originating  in 
the upper gastrointestinal(GI) tract (1). Other 
upper GI symptoms such as heartburn, 
postprandial fullness, and early satiety may 
be associated with it (2). Dyspepsia occurs 
frequently, and is the most common 
indication for upper GI endoscopy (2,3). 
Dyspepsia is also grouped into ulcer and non-
ulcer dyspepsia (4). Acid peptic disorder 
(APD) is a group of GI disorders in which 
acid and pepsin play a major role (4). Thus, 
APD encompasses conditions such as peptic 
oesophagitis usually as gastro-oesophageal 
reflux disease (GORD), gastritis, duodenitis 
or gastroduodenitis in addition to peptic ulcer 
disease, which may be gastric or duodenal 
(4).  Dyspepsia is the classic symptom of 
APD. Upper GI endoscopy is the 
investigation of choice in upper GI disorders 
which often present with dyspepsia (5,6).
F u n c t i o n a l  d y s p e p s i a  
(FD)(dyspepsia without an ulcer or non-ulcer 
dyspepsia) is 'the presence of symptoms 
thought to originate in the upper GI region in 
the absence of any organic, systemic or 
metabolic diseases that is likely to explain the 
symptoms' (7). FD is diagnosed at least twice 
as often as peptic ulceration (8).  The 
pathogenesis of FD is unknown, although 
gastric acid, duodeno-gastric reflux, 
heredity, environmental and psychological 
factors may play a role (8).
There have been numerous reports of 
the prevalence of FD. In one study, the 
prevalence of FD in the Scandinavian region 
was 20-25% in the general population (9). 
Other studies in USA and UK  reported 
prevalence rates of 25-40% (9-14). Majority 
of these studies suggested that FD represents 
more than 50% of all dyspepsia patients (15). 
A hospital-based study in Saudi Arabia found 
a prevalence of FD of 40% (16). Although FD 
is not a life-threatening disease, many studies 
have emphasized its clinical and economic 
effects such as loss of manpower hours, and 
its influence on the quality of life of sufferers 
(15,17-21).
Data is scanty on the prevalence of FD in 
black Africans. We therefore determined the 
prevalence of FD amongst dyspeptic patients 
in Yola, Nigeria.
MATERIALS AND METHODS
This was a hospital-based cross-
sec t ional  s tudy conducted  a t  the  
Gastroenterology unit of Federal Medical 
Centre, Yola from December, 2006 to 
October, 2010.Out-patients, in-patients, and 
referred patients with dyspepsia were 
recruited.  Patients with dyspepsia who 
underwent upper GI endoscopy as part of 
their work-up were consecutively recruited 
after a written and informed consent. All 
adult consenting patients with dyspepsia 
were recruited while patients who have had 
histamine 2 (H2) receptor blockers or proton 
pump inhibitors (PPIs)  in the previous two 
weeks were excluded.  Their biodata, history 
and duration of dyspepsia were noted on a 
proforma. The spectrum of endoscopic 
findings was also noted. 
The oesophagogastroduodenoscope 
in use at the endoscopy unit is a Fujinon 
(model FG-1Z) with an accompanying light 
source and an Olympus videoscope with a 
GIF-QX 240 gastroscope and a CLV- U40 
light source. All patients had upper GI 
endoscopy carried out on them after an 
overnight fast, and they had plain xylocaine 
(10%) applied to their pharynx prior to the 
procedure. 10mg of intravenous diazepam 
was also given to induce a short term amnesia 
in those in whom it was not contra-indicated. 
Thereafter the procedure was carried out 
according to standard protocol. Data was 
analysed, and the results presented as ratios 
and percentages. 
RESULTS
Four hundred and forty-one (441) 
patients were referred for upper GI 
endoscopy out of which 299 patients had 
dyspepsia. One hundred and eighty-six 
(62.2%) were females while 113(37.8%)  
weremales giving a female to male ratio of 
1.6:1. There was an increase in the age of the 
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study participants till the fifth decade i.e 40-
49 years, thereafter there was a decline. The 
age range was from 18 to 97 years with a 
mean of 47.6 ± 9.4 years (Table 1).
The commonest endoscopic finding 
was gastro-duodenitis seen in 190 (63.5%) 
patients while the least common findings 
were gastric and duodenal diverticulum seen 
in 1(0.3%) patient. A clinically significant 
endoscopic finding (CSFs) which reflects the 
organic lesions seen at endoscopy in the 
dyspeptic patients was 281(94.0%). Normal 
upper GI endoscopic study (functional 
dyspepsia) was seen in 18(6.0%) patients 
(Table 2).
DISCUSSION
The main aim of our study was to 
determine the occurrence of FD amongst 
patients with dyspepsia in Yola, Nigeria. 
From our study, 299 patients had dyspepsia 
comprising 37.8% males and 62.8% females 
with a mean age 47.6 ±9.4years. This pattern 
is similar to that of Jemilohun et al (22) in 
Ibadan, South-west Nigeria where they 
studied more females than males, and the 
mean age in  their study was 49.2+/-7.4years. 
However, our finding is different from that of 
Tijjani et al (23) in Kano, North-west Nigeria 
whose study population comprised more 
males than females, and with a mean age of 
37.8years.  
From our study, clinically significant 
endoscopic findings (CSFs) was seen in 
94.0% of dyspeptic patients. This is higher 
than the 82.1% found by Mustapha et al (5) in 
Maiduguri, North-eastern Nigeria. It is also 
higher than the 65.5% found by Tijjani et al 
(23) in Kano. Furthermore, it is higher than 
the 86.0% and 58.8% found by Al-Humayed 
et al (2) and Thompson et al (24) in Saudi 
Arabia and Canada respectively. The finding 
in our study, contrasts sharply with that of 
Olubuyide et al (25) in Ibadan, South-
western Nigeria who found that majority 
(55%) of their dyspeptic patients did not have 
any finding at endoscopy. The observed 
differences in CSFs in patients presenting 
with dyspepsia may be due to differences in 
sample sizes, and patient selection. 
Accessibility to endoscopic services, prior 
treatment for dyspepsia, presence of H. 
pylori infection and the time lag between the 
occurrence of dyspepsia and the performance 
of upper GI endoscopy may also play a role. 
From our study, the prevalence of FD was 
6.0%. There is a paucity of local and regional 
data on FD with which to compare. This 
finding of 6.0% prevalence for FD is lower 
than that seen in the study by El-serag and 
Talley (14) where a prevalence of 11.5-
14.7% was found. It is also lower than the 
findings of Bernersen et al (26) where a 
prevalence of 10-17.2% was seen among 
Scandinavians. Furthermore, Mahadeva and 
Goh (27) found a prevalence of 11-29.2%, 
while the study carried out by Shaib and El-
serag (13) revealed a prevalence of FD of 
29.2% among a cohort of multi-ethnic 
volunteers with dyspepsia in the United 
States. Our study was hospital-based, and the 
prevalence rate of FD from our study is lower 
than the earlier cited ones (9,13,15). Delayed 
presentation of our patients to  hospital, 
accessibility and affordability of endoscopic 
services, and prior intake of medications for 
dyspepsia might have influenced our  
endoscopic findings and accounted for this 
wide spectrum  of  findings at endoscopy. 
Differences in geographical location, 
environmental and lifestyle habits such as 
caffeine intake, smoking, socio-economic 
status, herbal medications, and use of 
NSAIDs may also have influenced our 
findings. The presence of H.pylori infection 
which varies greatly among population 
groups within the same country may also be 
an important factor.(27,28) This infection is 
reported to be more common in developing 
countries and varies between 70-90% as 
compared to 20-25% in developed countries 
(5,23,28-30). Various studies have shown 
that Nigeria has a high prevalence rate of 
H.pylori infection (22,30-32). Perhaps some 
yet to be identified factors may also be at play 
in influencing the low prevalence of FD 
amongst dyspeptic patients in our study.
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The main limitation in our study, is 
the relatively small sample size which may 
not be unconnected to the high cost of upper 
GI endoscopy in our environment. We also 
did not study the prevalence of H. pylori in 
our patients.
CONCLUSION
Majority of our patients with 
dyspepsia had CSFs, while only a minority 
had  FD. Larger, and more multi-centred 
studies which are population –based is 
advised to validate these findings especially 
in black Africans. 
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Table 1: Age and gender distribution of patients 
 
Age groups (Years)          Male (n)              Female (n)         Total (n)( %)  
 
       <19                       1  4  5(1.7) 
     20-29                      16  25  41(13.7) 
     30-39                    26  41  67(22.4) 
     40-49                    29  44  73(24.4) 
     50-59                   21  23  44(14.7) 
     60-69                  11  30  41(13.7) 
     70-79                   5  17  22(7.4) 
     80-89                  3  2  5(1.7) 
    90-99                1  0  1(0.3)   
     Total                  113(37.8) 186(62.2) 299(100.0)      




Table 2: Spectrum of endoscopic findings  
 
Endoscopic findings                                 Frequency (n)(%)  
 
Gastro-duodenitis                                    190(63.5) 
Reflux Oesophagitis                                81(27.1) 
Gastritis                                                   41(13.7) 
Duodenal ulcer                                        15(5.0) 
Gastric erosion                                        15(5.0) 
Hiatus hernia                                           12(4.0) 
Gastric ulcer                                            11(3.7) 
BarrettsOesophagus                               10(3.3) 
Duodenitis                                              6(2.0)                        
Oesophageal candidiasis                         6(2.0) 
Gastric cancer                                          4(1.3) 
Gastric polyp                                             4(1.3) 
Oesophageal cancer                            3(1.0) 
Gastric diverticulum                                  1(0.3) 
Duodenal diverticulum                              1(0.3) 
Clinically significant findings                     281(94.0)                             
Normal study (Functional dyspepsia)      18(6.0)       
______________________________________________________________________  
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